Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT00700609 Terminated - Depressive Disorder Clinical Trials

Family Based Treatment of Depressed Adolescents

BudFam
Start date: June 2008
Phase: Phase 2
Study type: Interventional

The purpose of this project is to assess the effectiveness of a family-based therapy (Attachment based family therapy-ABFT) for Norwegian adolescents (13-17 years) referred to specialist mental heath clinics.

NCT ID: NCT00695552 Terminated - Major Depression Clinical Trials

The Effect of Exercise on Depressive Symptoms in Unmedicated Patients

DEMOII
Start date: September 2008
Phase: N/A
Study type: Interventional

This trial investigates the biological effect of exercise training on depression. Participants will randomly be allocated to either a aerobic exercise group performing exercise on stationary bikes or a group performing low-impact exercise such as stretching exercises. Both groups will attend sessions three times per week for 3 months. Before and after the intervention the investigators will measure the severity of depression using the Hamilton depression rating scale (HAM-D17).

NCT ID: NCT00681668 Terminated - Clinical trials for Postpartum Depressive Disorder

Quetiapine in Postpartum Depression

Start date: August 2007
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the efficacy and tolerability of quetiapine in female patients with postpartum depressive disorder with psychotic symptoms

NCT ID: NCT00659347 Terminated - Clinical trials for Major Depressive Disorder

Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder

Start date: March 2008
Phase: Phase 2
Study type: Interventional

The primary objectives of this placebo-controlled trial are to evaluate effectiveness and safety of DOV 21,947 at two oral dose levels.

NCT ID: NCT00655226 Terminated - Depression Clinical Trials

Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients

Start date: March 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether cognitive behavioral therapy (CBT) is effective in the prevention of depression during interferon and ribavirin treatment for hepatitis C infection.

NCT ID: NCT00643162 Terminated - Depression Clinical Trials

Combination Lexapro and Massage for Treatment of Depression in Older Adults

Start date: June 2006
Phase: N/A
Study type: Interventional

Depression is a common and disabling condition which represents a substantial public health concern, especially with the aging of the population in general. In fact, one to four percent of the older population has major depression. Although medication is the main treatment for depression, studies show that only 50% of patients show a significant response to treatment. The response might actually be less in older subjects, and with more adverse side effects due to changes in the metabolism of the older population as well as drug interaction. For these reasons (changes in metabolism and possible drug interactions) the starting dose of the antidepressant Lexapro will be 5mg, instead of 10mg. To combat the incomplete response to medication, many combined and augmentation strategies have been developed. Examples of this would be an antidepressant medication plus a neuroleptic medication; or an antidepressant medication plus talk therapy. One non-medication treatment that is being considered is massage therapy. Recent data suggest that massage therapy can be useful for the treatment of depression. This study proposes to perform a controlled trail to assess the effects of massage therapy on symptoms of depression in older subjects with major depression. All of the subjects will receive Lexapro, which is an FDA approved medication for the treatment of depression. Half of the subjects will receive Swedish massage for one hour, twice a week, and the other half will receive light touch for one hour, twice per week for eight weeks. Standardized rating scales that evaluate depression will be used to evaluate the subjects mood.

NCT ID: NCT00642694 Terminated - Clinical trials for Major Depressive Disorder

Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon

TAKEDA
Start date: May 2007
Phase: Phase 3
Study type: Interventional

Hypothesis I: Patients in the SSRI + ramelteon treatment group will achieve remission (defined as an IDS-C30 score of 11 or less) more quickly than those in the SSRI + placebo group.

NCT ID: NCT00637494 Terminated - Psychosis Clinical Trials

A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Start date: March 2008
Phase: Phase 3
Study type: Interventional

Approximately 450 patients will be randomized to receive Mifepristone or placebo for 7 days followed by antidepressant. The purpose is to compare the efficacy of Mifepristone followed by antidepressant versus placebo followed by antidepressant in reducing psychotic symptoms in patients with a diagnosis of psychotic depression.

NCT ID: NCT00623298 Terminated - Depression Clinical Trials

Narrative Exposure Therapy Versus Group Interpersonal Psychotherapy

Start date: January 2005
Phase: Phase 2
Study type: Interventional

The present study is a pragmatic trial that investigates the efficacy and usefulness of two treatment modules in a sample of Rwandan genocide orphans: Narrative Exposure Therapy (NET) versus group-Interpersonal Psychotherapy (IPT). We used a half year baseline to measure the treatment-induced changes. We hypothesized that there would be a greater reduction in posttraumatic stress symptoms in the NET- than in the IPT-group and that IPT would be superior to NET in the reduction of depression symptoms.

NCT ID: NCT00622947 Terminated - Depressive Disorder Clinical Trials

The Antidepressant Effect of Right Temporal Low Frequency rTMS Compared to Sham

Start date: February 2008
Phase: N/A
Study type: Interventional

The aim of the present study is to compare the antidepressant effect of low frequency rTMS applied over the right temporal cortex with sham stimulation.